Sepsis | Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

Sepsis research study

What is the primary objective of this study?

The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.

Who is eligible to participate?

Inclusion Criteria: - diagnosis: acute myeloid leukaemia - age under 70 years - neutropenic fever Exclusion Criteria: - age above 70 years - no neutropenic fever

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:Severe sepsis vs. non-severe sepsisTo compare these two groups

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Neutropenic patientsAdult AML and ASCT patients with neutropenic fever.

Study Status


Start Date: December 2006

Completed Date: January 1, 2019


Type: Observational


Primary Outcome: This study evaluates epidemiology, microbiology and outcome of neutropenic fever and severe sepsis in haematological patients with special reference to the kinetics of inflammatory markers.

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Esa Jantunen, M.D, PhD

Lead Sponsor: Kuopio University Hospital


More information:

Discuss Sepsis